Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_390040c6e624ea53bcbde890870ae7d4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-265 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-265 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 |
filingDate |
2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efb1f36bfe18816a2a8efa10c0a89df2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cca91f19bd42aff75da778474dae174b |
publicationDate |
2018-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2652352-C2 |
titleOfInvention |
Combination of levocabastine and fluticasone furoate for the treatment of inflammatory and/or allergic conditions |
abstract |
FIELD: medicine; pharmaceuticals. n SUBSTANCE: present invention relates to a pharmaceutical composition of levocabastine or a salt thereof and fluticasone furoate for the treatment of an inflammatory and/or allergic condition, especially rhinitis; to a device adapted for intranasal delivery of a pharmaceutical formulation; to a method for the treatment of allergic rhinitis; the use of a pharmaceutical composition for the treatment of patients with an inflammatory and/or allergic condition, as well as to a method for treatment of a person with an inflammatory and/or allergic condition. n EFFECT: invention allows to obtain a composition of levocabastine and fluticasone furoate with increased efficacy in the treatment of allergic rhinitis as compared to individual components. n 30 cl, 2 ex, 13 dwg |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2736082-C1 |
priorityDate |
2012-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |